GB0724340D0 - Novel Therapeutic Agents - Google Patents

Novel Therapeutic Agents

Info

Publication number
GB0724340D0
GB0724340D0 GBGB0724340.5A GB0724340A GB0724340D0 GB 0724340 D0 GB0724340 D0 GB 0724340D0 GB 0724340 A GB0724340 A GB 0724340A GB 0724340 D0 GB0724340 D0 GB 0724340D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
novel therapeutic
novel
agents
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0724340.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Dundee filed Critical University of Dundee
Priority to GBGB0724340.5A priority Critical patent/GB0724340D0/en
Publication of GB0724340D0 publication Critical patent/GB0724340D0/en
Priority to EP08859006A priority patent/EP2231140A1/en
Priority to PCT/GB2008/004109 priority patent/WO2009074809A1/en
Priority to JP2010537515A priority patent/JP2011506416A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0724340.5A 2007-12-13 2007-12-13 Novel Therapeutic Agents Ceased GB0724340D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0724340.5A GB0724340D0 (en) 2007-12-13 2007-12-13 Novel Therapeutic Agents
EP08859006A EP2231140A1 (en) 2007-12-13 2008-12-12 Sigma ligands and ikk / nf - kb inhibitors for medical treatment
PCT/GB2008/004109 WO2009074809A1 (en) 2007-12-13 2008-12-12 Sigma ligands and ikk / nf - kb inhibitors for medical treatment
JP2010537515A JP2011506416A (en) 2007-12-13 2008-12-12 Medical sigma ligand and IKK / NF-κB inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0724340.5A GB0724340D0 (en) 2007-12-13 2007-12-13 Novel Therapeutic Agents

Publications (1)

Publication Number Publication Date
GB0724340D0 true GB0724340D0 (en) 2008-01-30

Family

ID=39048074

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0724340.5A Ceased GB0724340D0 (en) 2007-12-13 2007-12-13 Novel Therapeutic Agents

Country Status (4)

Country Link
EP (1) EP2231140A1 (en)
JP (1) JP2011506416A (en)
GB (1) GB0724340D0 (en)
WO (1) WO2009074809A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0821093D0 (en) * 2008-11-18 2008-12-24 Modern Biosciences Plc Treatment
CN109512805B (en) 2012-05-08 2021-12-31 埃罗米克斯公司 Compounds for the treatment of aquaporin mediated diseases
CN105636583B (en) 2013-09-13 2019-08-20 板井昭子 Aqueous solution preparation and its manufacturing method
JP6535338B2 (en) 2013-11-06 2019-06-26 エアロミクス・インコーポレイテッドＡｅｒｏｍｉｃｓ，Ｉｎｃ． New formulation
WO2017106312A1 (en) * 2015-12-18 2017-06-22 Drexel University Methods of modulating levels of il-6 and pd-l1
US20200000822A1 (en) * 2017-02-23 2020-01-02 Board Of Regents, The University Of Texas System Methods of treatment for cancer, sterol homeostasis, and neurological diseases
EP3666770A4 (en) * 2017-08-07 2021-04-07 Joint Stock Company "Biocad" Novel heterocyclic compounds as cdk8/19 inhibitors
WO2023120963A1 (en) * 2021-12-21 2023-06-29 한국과학기술연구원 Pharmaceutical composition for preventing or treating lung cancer comprising carbazole derivative compound as active ingredient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9814036D0 (en) * 1998-06-29 1998-08-26 Univ Dundee Materials and methods relating to the induction of apoptosis in target cells

Also Published As

Publication number Publication date
JP2011506416A (en) 2011-03-03
EP2231140A1 (en) 2010-09-29
WO2009074809A1 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
EP2117311A4 (en) Therapeutic agents
GB0811304D0 (en) Therapeutic agents
HRP20130041T8 (en) Therapeutic agents
GB0609492D0 (en) Therapeutic agents
GB0608928D0 (en) Therapeutic agents
GB0601962D0 (en) Therapeutic agents
GB0811643D0 (en) New therapeutic agents
GB0616214D0 (en) Therapeutic Agents
GB0819593D0 (en) Therapeutic agents
GB0723747D0 (en) Therapeutic agents
GB0821693D0 (en) Therapeutic agents
GB0611152D0 (en) Therapeutic agents
GB0812309D0 (en) Therapeutic agents
GB0805818D0 (en) Therapeutic agents
GB0724340D0 (en) Novel Therapeutic Agents
GB0801080D0 (en) Therapeutic agents
GB0801081D0 (en) Therapeutic agents
GB0620818D0 (en) Therapeutic agents
GB0620059D0 (en) Therapeutic agents
GB0609676D0 (en) Therapeutic agents
GB0723748D0 (en) Therapeutic agents
EP2454276A4 (en) Therapeutic agents
GB0808690D0 (en) Therapeutic use
GB0622195D0 (en) Therapeutic agents
GB0811715D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)